Scarica l'app Stockscreener
302.74
2.17%
-6.96
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WST Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
Deutsche Bank Adjusts West Pharmaceutical Services PT to $340 From $315, Maintains Buy Rating - marketscreener.com
Jefferies Adjusts West Pharmaceutical Services Price Target to $365 From $295, Maintains Buy Rating - marketscreener.com
TD Cowen Adjusts West Pharmaceutical Services PT to $365 From $350, Maintains Buy Rating - marketscreener.com
West Pharmaceutical: A High-Quality Beat-And-Raise With More Upside Ahead - Seeking Alpha
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2026 Earnings Call Transcript - Insider Monkey
West Pharmaceutical Services Q1 Earnings Call Highlights - Yahoo Finance
West Pharmaceutical Services Inc (WST) Q1 2026 Earnings Call Hig - GuruFocus
WST Q1 Deep Dive: High-Value Components and Operational Execution Drive Outperformance - TradingView
West Pharmaceutical: Q1 Earnings Snapshot - theheraldreview.com
West Pharma lifts 2026 profit forecast on strong demand for medical equipment - 1470 & 100.3 WMBD
West Pharmaceutical Lifts Outlook After Powerful Q1 - TipRanks
BofA raises West Pharmaceutical stock price target on strong quarter By Investing.com - Investing.com Canada
A Look at West Pharmaceutical Services Inc (WST) After 12.9% Gai - GuruFocus
TD Cowen raises West Pharmaceutical stock price target on guidance By Investing.com - Investing.com Australia
West Pharma sees plastics, elastomer demand surge with GLP-1 growth - Rubber News
[10-Q] WEST PHARMACEUTICAL SERVICES INC Quarterly Earnings Report - Stock Titan
WST Stock Climbs As Dublin Expansion Targets GLP‑1 Drug Wave - StocksToTrade
WST Stock Climbs As Dublin Expansion Targets GLP-1 Drug Boom - timothysykes.com
West Pharmaceutical Lifts Annual Guidance After Strong GLP-1 Driven Growth In Q1 - Benzinga
West Pharmaceutical Services, Inc. Raises Earnings Guidance for the Full Year 2026 - marketscreener.com
West Pharma jumps as packaging components drive strong Q1 beat - MSN
West Pharmaceutical Services Q1 2026 Earnings Call Transcript - MarketBeat
Evercore ISI raises West Pharmaceutical price target on strong results By Investing.com - Investing.com Canada
West Pharmaceutical Services, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
West Pharmaceutical Stock Is Soaring After Earnings. It’s a Sneaky GLP-1 Play. - Barron's
WST Stock Jumps on Q1 Earnings & Sales Beat, EPS View Up on HVP Growth - TradingView
WST Stock Climbs As Dublin Expansion Targets GLP‑1 Drug Boom - StocksToTrade
West Pharmaceutical Services Reports Strong Q1 2026 Results Driven by Double-Digit Organic Net Sales Growth - Minichart
West Pharmaceutical (WST) jumps on Q1 beat and raised 2026 outlook - Quiver Quantitative
West Pharmaceutical Services Stock Climbs As Dublin Expansion Targets Obesity Drug Boom - timothysykes.com
West Pharmaceutical Q1 2026 slides: 47% EPS surge on biologics boom - Investing.com
West Pharmaceutical Services Crushes Q1 2026 Profit Estimates by 26.0% - AlphaStreet
West Pharmaceutical Q1 2026 slides: 47% EPS surge on biologics boom By Investing.com - Investing.com South Africa
West Pharma Sees FY EPS $8.15-EPS $8.50 >WST - Moomoo
West Pharmaceutical Services CEO Eric Green plans to retire after successor is named - MSN
Compared to Estimates, West Pharmaceutical (WST) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Earnings call transcript: West Pharmaceutical Services Q1 2026 beats expectations - Investing.com Canada
West Pharmaceutical Services, Inc. Provides Earnings Guidance for the Second Quarter 2026 - marketscreener.com
West Pharma stock jumps after strong Q1 beat (WST:NYSE) - Seeking Alpha
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Is West Pharmaceutical (WST) 23.2% Undervalued After Q1 2026 Bea - GuruFocus
West Pharmaceutical Raises 2026 Outlook After Strong Quarter - TipRanks
West Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Form 8-K WEST PHARMACEUTICAL SERV For: Apr 23 - StreetInsider
West (NYSE: WST) posts 21% Q1 sales growth and raises 2026 guidance - Stock Titan
Why West Pharmaceutical Services Stock Is Dropping Now - TipRanks
WEST PHARMACEUTICAL SVSC ($WST) Releases Q1 2026 Earnings - Quiver Quantitative
(WST) West Pharmaceutical Services Expects Full Year 2026 Adjusted EPS Range $8.40$8.75, vs. FactSet Est of $8.01 - marketscreener.com
(WST) West Pharmaceutical Expects 2026 Revenue Range $3.3B$3.35B, vs. FactSet Est of $3.25B - marketscreener.com
(WST) West Pharmaceutical Services, Inc. Expects Q2 Revenue Range $830.0M$850.0M - marketscreener.com
(WST) West Pharmaceutical Services, Inc. Expects Q2 Adjusted EPS Range $2.05$2.12 - marketscreener.com
Earnings Flash (WST) West Pharmaceutical Services, Inc. Reports Q1 Revenue $844.9M, vs. FactSet Est of $780.3M - marketscreener.com
Earnings Flash (WST) West Pharmaceutical Services, Inc. Posts Q1 Adjusted EPS $2.13 per Share, vs. FactSet Est of $1.68 - marketscreener.com
West Pharmaceutical Services (NYSE:WST) Surprises With Strong Q1 CY2026, Stock Soars - Yahoo Finance
West Reports First-Quarter 2026 Results - The Malone Telegram
West Pharmaceutical Q1 2026 earnings preview - MSN
West Pharmaceutical earnings loom as GLP-1 exposure in focus By Investing.com - Investing.com Australia
West Pharmaceutical earnings loom as GLP-1 exposure in focus - Investing.com
Earnings To Watch: West Pharmaceutical Services (WST) Reports Q1 Results Tomorrow - Yahoo Finance
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
WST Likely to Beat Q1 Earnings Estimates: How to Play the Stock? - TradingView
Exploring Analyst Estimates for West Pharmaceutical (WST) Q1 Earnings, Beyond Revenue and EPS - Yahoo Finance
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services (WST): Strong Buy Ratings And A Promising 15.98% Upside - DirectorsTalk Interviews
Reasons to retain West Pharmaceutical stock in your portfolio for now - MSN
West Pharmaceutical Services, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Assessing West Pharmaceutical Services (WST) Valuation After Recent Share Price Momentum - Sahm
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):